Biotechnology

Global Cord Blood Corporation Announces Results of 2021 Annual General Meeting

HONG KONG, Dec. 7, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced the results of its 2021 Annual Gene...

2021-12-07 21:35 3256

Sino Biological newly launched a panel of research reagents for SARS-CoV-2 Omicron variant

BEIJING, China, Dec. 7, 2021 /PRNewswire/ -- Sino Biological, Inc. ( http://www.sinobiological.com ; SHE: 301047) announced today that it has launched a panel of research reagents for the newly identified Omicron variant (B.1.1.529) of the SARS-COV-2 virus, which qu...

2021-12-07 18:18 5351

Sustainable Superfoods: Sophie's BioNutrients Aims to Replace Soy as a Commercially Viable Protein Alternative within 5 years

SINGAPORE, Dec. 6, 2021 /PRNewswire/ -- Sophie's Bionutrients, a next-generation sustainable urban food production technology company, is shaping the future of food with high moisture extrusion (HME) technology and microalgae fermentation. This process is a revolutionary development in the plant...

2021-12-06 21:06 3709

RedHill Biopharma Reports that Opaganib Mechanism Not Impacted by Viral Spike-Protein Mutations, Including Omicron Mutations

Unique Mode of Action Opaganib works by targeting the human host cell rather than the virus itself and is therefore not expected to be impacted by spike protein mutations, providing a strong rationale for its potential to address the Omicron SARS-CoV-2 variant, as well as other variants of conce...

2021-12-06 20:01 4835

Innoforce Completes Second Tranche of Series A Financing

HANGZHOU, China, Dec. 6, 2021 /PRNewswire/ -- Innoforce ("INF"), a biopharmaceutical manufacturing & development company, announced today the completion of a1 billion CNY ($156.6M) Series A financing, with the closing of an additional375M CNY ($58.7M) following the first tranche of 625M CNY ($96M...

2021-12-06 20:00 3168

Donisi Health Named 2021's "Future Unicorn" by E&T Magazine

MedTech Startup Focused on Home Monitoring for Patients with Congestive Heart Failure and Other Chronic Diseases Receives the "Future Unicorn" Innovation Award from E&T TEL AVIV, Israel, Dec. 6, 2021 /PRNewswire/ -- E&T Magazine, the official publication of the Institution of Engineering and Tec...

2021-12-06 18:59 2713

Hummingbird Bioscience Announces First Patient Dosed in Phase 1 Clinical Trial of HMBD-001 in Advanced HER3-Expressing Solid Malignancies

HOUSTON and SINGAPORE, Dec. 6, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets in cancer and autoimmune disease, and Cancer Research UK, the world's leading cancer charity, today annou...

2021-12-06 17:30 2015

Henlius' 4th Biologics: Bevacizumab Biosimilar Hanbeitai Approved by National Medical Products Administration

SHANGHAI, Dec. 4, 2021 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that bevacizumab biosimilar Hanbeitai, developed and manufactured by Henlius independently, has been approved by the National Medical Products Administration (NMPA). It is indicated for the treatment of meta...

2021-12-04 01:51 6925

Starpharma signs distribution agreement for VIRALEZE™ antiviral nasal spray in Vietnam

* Starpharma has signed a 5-year supply and distribution agreement for VIRALEZE™ inVietnam * The agreement includes a minimum commitment of 1 million units in the first year * VIRALEZE™ is scheduled to be officially launched in Vietnam today, following its registration for sale this week ...

2021-12-03 14:24 3413

Joint CUHK-HKU study discovers efficacy of COVID-19 vaccines correlates with a probiotic bacterium, Bifidobacterium adolescentis

HONG KONG, Dec. 2, 2021 /PRNewswire/ -- The Centre for Gut Microbiota Research of the Faculty of Medicine at TheChinese University of Hong Kong (CU Medicine) is among the first in the world to discover that germs in our gut (gut microbiota) modulate our immunity and disease severity in COVID-19. ...

2021-12-02 21:00 16533

Hohem iSteady V2 Won the 20th Shenzhen Enterprise Innovation Record (Global)

SHENZHEN, China, Dec. 2, 2021 /PRNewswire/ -- The 20th Shenzhen Enterprise Innovation Record awards was announced onNovember 26, 2021. Shenzhen Hohem Technology Co. Ltd (hereinafter referred to as Hohem) won the 20th Shenzhen Enterprise Innovation Record (Global) for its product iSteady V2 and th...

2021-12-02 17:29 4323

Publication in The New England Journal of Medicine Confirms that Tens of Thousands of Women with Node-positive, Early-stage Breast Cancer Can Avoid Chemotherapy with the Oncotype DX® Test

- RxPONDER, an independent study led by SWOG Cancer Research Network, demonstrates that guiding treatment with Oncotype DX test can spare chemotherapy use in majority of postmenopausal women - Results have already led to updated NCCN Guidelines® for breast cancer - New RxPONDER results to be fea...

2021-12-02 16:00 3403

EZZ bolsters Board with industry veteran Glenn Cross as new Chair

SYDNEY, Dec. 2, 2021 /PRNewswire/ -- EZZ Life Science Holdings Limited (ASX: EZZ), a genomic life science company with a mission to improve quality of life and human health, has strengthened its leadership team with the appointment of experienced biotechnology professionalGlenn Cross as its new C...

2021-12-02 05:00 2828

SOPHiA GENETICS Announces Launch of DEEP-Lung-IV Multimodal Clinical Study

Study to leverage deep learning-enabled analysis of the aggregation of real-world multimodal data to validate predictive signatures associated with response to immunotherapy and prognosis of patients with stage IV non-small cell lung cancer Large-scale, multicentric real-world study aims to enro...

2021-12-02 02:30 2702

Dr. Aletta Schnitzler Joins TurtleTree as Chief Scientific Officer

DAVIS, Calif. and SINGAPORE, Dec. 1, 2021 /PRNewswire/ -- Cell-based nutrition company TurtleTree welcomes Dr.Aletta Schnitzler as its new Chief Scientific Officer (CSO). With her world-class expertise in cellular bioprocessing, Dr. Schnitzler's appointment marks a significant stride in TurtleTre...

2021-12-01 23:00 3035

VIRALEZE™ antiviral nasal spray registered in Vietnam with launch to follow this week

MELBOURNE, Australia, Dec. 1, 2021 /PRNewswire/ -- Australian biotech company Starpharma  today announced that its broad spectrum antiviral nasal spray, VIRALEZE™, has been registered for sale inVietnam, with the product scheduled to launch inVietnam this week. VIRALEZE™...

2021-12-01 16:40 2921

GenScript and BioComo Join Forces to Accelerate Novel Intranasal SARS-CoV-2 Vaccine Development in Japan

TOKYO and SINGAPORE, Dec. 1, 2021 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a leading global biotechnology company, and BioComo Incorporation, a drug discovery venture based in Mie prefecture,Japan, today announces a strategic agreement for joint research a...

2021-12-01 12:03 6199

Sai Life Sciences' pharmaceutical API manufacturing site receives Certificate of Inspection from PMDA, Japan

HYDERABAD, India, Dec. 1, 2021 /PRNewswire/ -- Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization  (CRO/ CDMO), today announced that the Japanese regulatory...

2021-12-01 09:00 3844

Silexon Partners with Excelra, Deploying GOSTAR to Strengthen its AI-driven Drug Discovery and Biopharmaceutical Research Platform

HYDERABAD, India and NANJING, China, Dec. 1, 2021 /PRNewswire/ -- Excelra, a leading global data & analytics provider, today announced its partnership with Silexon AI Technology, a next-generation biotech company with a scalable AI/ML (Artificial Intelligence and Machine Learning) platform for dr...

2021-12-01 08:05 3762

Lynk Pharmaceuticals Announced First Patient Dosed in Phase II Clinical Study of LNK01001

HANGZHOU, China, Dec. 1, 2021 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced the company has dosed the first patient with LNK01001 in its Phase II clinical trial in subjects with rheumatoid arthri...

2021-12-01 08:00 4489
1 ... 159160161162163164165 ... 185

Week's Top Stories